Broker Recommendations West Pharmaceutical Services, Inc.

Stocks

WST

US9553061055

Medical Equipment, Supplies & Distribution

Real-time Estimate Cboe BZX Other stock markets 01:30:29 17/07/2026 am IST			5-day change	1st Jan Change
349.96 ^USD	-2.52%		+1.13%	+31.46%

15/07	TD Cowen Adjusts Price Target on West Pharmaceutical Services to $410 From $365, Maintains Buy Rating	MT
15/07	West Pharmaceutical Services, Inc. and Daikyo Seiko, Ltd. Enter Distributorship Agreements	CI

Broker Recommendations

15/07	TD Cowen Adjusts Price Target on West Pharmaceutical Services to $410 From $365, Maintains Buy Rating	MT
13/07	BNP Paribas Initiates West Pharmaceutical Services at Outperform With $447 Price Target	MT
13/07	BNP Paribas Initiates West Pharmaceutical Services at Outperform With $447 Price Target	MT
09/07	Morgan Stanley Adjusts Price Target on West Pharmaceutical Services to $365 From $325	MT
06/07	Evercore ISI Adjusts Price Target on West Pharmaceutical Services to $410 From $390	MT
02/07	KeyBanc Adjusts PT on West Pharmaceutical Services to $390 From $350, Maintains Overweight Rating	MT
09/06	Barclays Upgrades West Pharmaceutical Services to Overweight From Equalweight, Adjusts PT to $400 From $310	MT
28/05	Morgan Stanley Adjusts West Pharmaceutical Services PT to $325 From $315, Keeps Equalweight Rating	MT
24/04	Stephens Adjusts Price Target on West Pharmaceutical Services to $360 From $320, Maintains Overweight Rating	MT
24/04	Deutsche Bank Adjusts West Pharmaceutical Services PT to $340 From $315, Maintains Buy Rating	MT
24/04	Rothschild & Co Redburn Adjusts West Pharmaceutical Services Price Target to $353 From $312, Maintains Buy Rating	MT
24/04	Jefferies Adjusts West Pharmaceutical Services Price Target to $365 From $295, Maintains Buy Rating	MT
24/04	Citigroup Adjusts West Pharmaceutical Services PT to $400 From $375, Maintains Buy Rating	MT
24/04	Evercore ISI Adjusts West Pharmaceutical Services PT to $390 From $320, Maintains Outperform Rating	MT
24/04	TD Cowen Adjusts West Pharmaceutical Services PT to $365 From $350, Maintains Buy Rating	MT
14/04	Barclays Adjusts Price Target on West Pharmaceutical Services to $275 From $265, Maintains Equalweight Rating	MT
17/02	Rothschild & Co Redburn Adjusts Price Target on West Pharmaceutical Services to $312 From $325, Maintains Buy Rating	MT
13/02	Stephens Cuts Price Target on West Pharmaceutical Services to $320 From $350, Maintains Overweight Rating	MT
13/02	UBS Adjusts West Pharmaceutical Services Price Target to $340 From $355, Maintains Buy Rating	MT
13/02	Barclays Adjusts West Pharmaceutical Services PT to $265 From $325, Maintains Equal Weight Rating	MT
10/02	Jefferies Adjusts Price Target on West Pharmaceutical Services to $295 From $365, Maintains Buy Rating	MT
03/02	Evercore ISI Adjusts Price Target on West Pharmaceutical Services to $320 From $390	MT
19/12	Deutsche Bank Adjusts West Pharmaceutical Services Price Target to $340 From $345, Maintains Buy Rating	MT
02/12	Morgan Stanley Initiates West Pharmaceutical Services at Equalweight With $285 Price Target	MT
31/25/31	Rothschild & Co Redburn Adjusts Price Target on West Pharmaceutical Services to $325 From $311	MT